The development of dialysis by early pioneers such as Willem Kolff and Belding Scribner set
in motion several dramatic changes in the epidemiology, economics and ethical frameworks …

Cardiovascular (CV) disease remains an important cause of morbidity and mortality for
patients with chronic kidney disease (CKD). Although clustering of traditional risk factors with …

Chronic kidney disease (CKD) is a worldwide health problem with steadily increasing
occurrence. Significantly elevated cardiovascular morbidity and mortality have been …

Over the last decades, childhood and adolescence have emerged as an important window
of opportunity to prevent atherosclerotic cardiovascular disease (ASCVD) later in life. Here …

Intradialytic hypotension, defined as rapid decrease in systolic blood pressure of greater
than or equal to 20 mmHg or in mean arterial pressure of greater than or equal to 10 mmHg …

Background/Purpose End-stage kidney disease (ESKD) is a global burden that reflects each
country's unique condition. We used the National Health Insurance Research Database …

Background: Autonomic nervous regulation plays a critical role in end-stage kidney disease
(ESKD) patients with cardiovascular complications. However, studies on autonomic …

Immunosenescence is the deterioration of the innate and adaptive immune systems
associated with aging and is primarily characterized by a reduction in T cell production and …

Kidney failure affects a significant part of the world's population where more than 2 million
people currently undergoing some sort of treatment for end-stage kidney disease (ESKD) …

Bone marrow-derived mesenchymal stem cells (MSCs) show antifibrotic activity in various
chronic kidney diseases. Here, we aimed to investigate whether Calycosin (CA), a …